| RS2067393549 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067393679 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067394045 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067399344 |
RPS6KA3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2067404808 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, RPGR-related retinopathy |
| RS2067406342 |
RPGR
|
Health Risk |
Pathogenic |
Retinal dystrophy, Primary ciliary dyskinesia |
| RS2067408614 |
RPGR
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2067410562 |
RPGR
|
Health Risk |
Pathogenic |
— |
| RS2067429826 |
DPH1
|
Health Risk |
Pathogenic |
Developmental delay with short stature, dysmorphic facial features |
| RS2067434779 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067434947 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Ovarian serous cystadenocarcinoma |
| RS2067440192 |
SBF1
|
Health Risk |
Pathogenic |
— |
| RS2067447633 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067448379 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067448565 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, Primary ciliary dyskinesia |
| RS2067448681 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2067448975 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067449346 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067449493 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067449536 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067449854 |
RPGR
|
Health Risk |
Pathogenic |
Retinal dystrophy, Primary ciliary dyskinesia |
| RS2067449978 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067450400 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067450430 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067451355 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Primary ciliary dyskinesia |
| RS2067451446 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067453631 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2067468999 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067475470 |
RPS6KA3
|
Health Risk |
Likely pathogenic |
Coffin-Lowry syndrome, Coffin-Lowry syndrome |
| RS2067498051 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2067498092 |
RPGR
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Retinal dystrophy |
| RS2067506937 |
JAG1
|
Health Risk |
Pathogenic |
Tetralogy of Fallot, Tetralogy of Fallot |
| RS2067508256 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067513100 |
JAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Alagille syndrome due to a JAG1 point mutation |
| RS2067513720 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2067562201 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2067562961 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 6, Retinitis pigmentosa 6 |
| RS2067565504 |
RPGR
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, RPGR-related retinopathy |
| RS2067589435 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2067592710 |
ASXL3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2067594520 |
ASXL3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2067595880 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2067597172 |
FLNA
|
Health Risk |
Likely pathogenic |
Melnick-Needles syndrome, Heterotopia |
| RS2067597244 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2067597366 |
ASXL3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2067598008 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS2067600337 |
ASXL3
|
Health Risk |
Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2067601254 |
ASXL3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2067602034 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type II |
| RS2067603110 |
ASXL3
|
Health Risk |
Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2067607089 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS2067607133 |
ASXL3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2067607599 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2067614941 |
SYNE1
|
Health Risk |
Likely pathogenic |
— |
| RS2067616141 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2067620152 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067620305 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067620512 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067621019 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067621208 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067621676 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067621912 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067623178 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067623782 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067623934 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067626336 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Heterotopia |
| RS2067631656 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS2067635690 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS2067635955 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067636699 |
ASXL3
|
Health Risk |
Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2067637088 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067638831 |
SLC4A11
|
Health Risk |
Likely pathogenic |
— |
| RS2067639563 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS2067642748 |
ASXL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2067643753 |
ASXL3
|
Health Risk |
Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2067650699 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type I |
| RS2067654837 |
SLC4A11
|
Health Risk |
Likely pathogenic |
Congenital hereditary endothelial dystrophy of cornea, Corneal dystrophy |
| RS2067664000 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067664784 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067665969 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS2067666266 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2067676221 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2067676994 |
FLNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiac valvular dysplasia, X-linked |
| RS2067677205 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS2067679229 |
SLC4A11
|
Health Risk |
Conflicting classifications of pathogenicity |
Corneal dystrophy, Corneal dystrophy |
| RS2067679756 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2067683151 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS2067687057 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Oto-palato-digital syndrome, type II |
| RS2067688143 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2067688726 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS2067688959 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067689357 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067689582 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067690116 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067690233 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067690686 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067691272 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Oto-palato-digital syndrome, type II |
| RS2067691394 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067691658 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067692232 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |